Guerra Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Guerra Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$5.06K	Buy	+9	New	+$5.09K	﹤0.01%	400

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Guerra Advisors's REGN Position: Q3 2025 in Review

Guerra Advisors opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2025: 9 shares worth $5.06K. The stake represents ﹤0.01% of the portfolio and ranks #400 among its holdings.

1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

Guerra Advisors held 9 shares of Regeneron Pharmaceuticals worth $5.06K as of Q3 2025.
Regeneron Pharmaceuticals was a new Guerra Advisors position in Q3 2025.
Regeneron Pharmaceuticals made up ﹤0.01% of Guerra Advisors's portfolio in Q3 2025, its #400 holding.
1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.